4//SEC Filing
Knappertz Volker 4
Accession 0001600620-24-000022
CIK 0001600620other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:35 PM ET
Size
5.0 KB
Accession
0001600620-24-000022
Insider Transaction Report
Form 4
Knappertz Volker
EVP, Research and Development
Transactions
- Sale
Common Stock
2024-02-20$5.48/sh−25,146$137,800→ 324,058 total
Footnotes (2)
- [F1]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant.
- [F2]Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 shares of common stock were acquired on May 31, 2023 and 2,430 shares of common stock were acquired on November 30, 2023.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001754122
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:35 PM ET
- Size
- 5.0 KB